RE:RE:RE:Realistically....Relax.. The market has cooled and yes, on top of that, Acg hurt themselves via the halt. Not sure how that makes any other chirp on management relevant tho, nor how it changes any expectations. Nothing but progress has been achieved since Nov, but nothing to warrant the 1.30 we touched. This thing ran up on hopes of fast news and big gains. Reality hit, and if u got stuck holding bags and ur not happy, then you should have bailed out. If your long, it’s just a bumpy ride. Lots of channels for income here. If they all pan out, we have a 5+ share price in a year, if only a few channels workout, for example Quebec biocanna doesn’t get LP, there is still global and BC. Very little money locked into biocanna until they reach a point of technicality and the LP is a lock. Govt doesn’t just watch u spend millions in wasted greenhouse construction, just to say nah, no license for you. And we have little $ in bio until construction underway and only about half upon test crop.. the business model is safe financially, allows for failures while still maintaining a rev stream, and taps into many product lines; plantlets, bud, extract, r&d, pharma and all med grade. And globally driven, as Jamaica is a great example of expansion.. plus this cbd DANA hemp strain could be the Monsanto of hemp strains. 10%+ cbd to .3% thc.. unheard of.. huge potential for tapping into the exponentially growing cbd market (pharma = $$$)
$24M cap... looking at all this potential revenue, and a lot of it not as risky as it seems.. I’m comfy.